Getting drugs and devices to the doorstep is only half the battle. When digital connections fail, trials fail. Why the digital last mile needs clinical supply ownership, human-centered design, and tech support with a bedside manner.
- The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
- Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
- How AI Is Rewriting The Future Of TMF And Clinical Quality
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Introducing Digitally-Enabled Biosample Consent Storage
Despite the rise of digital solutions in healthcare, paper consent forms are still common in today’s clinical trials. Unfortunately, these paper forms pose significant challenges in retaining the documentation of informed consent for centrally stored biospecimens.
-
eCOA Predictions For 2022
Dive into the prediction that the rapid adoption of eCOAs will continue to grow in 2022, as sponsors acknowledge how useful these tools have become in decentralized clinical trial (DCT) settings.
-
A Beginner's Guide To Compliant Electronic Source Data Capture
With today’s complex trials, the expectation of gathering faster results in an increasingly decentralized environment is only increasing, imploring investigators to implement electronic source data capture systems. How can researchers ensure this is done correctly? Leveraging the right technology to standardize a compliant process for source data capture is a proven way to reach these goals.
-
Navigating The eCOA Vendor Landscape In 2025
This guide offers a clear-eyed perspective on the current eCOA landscape, providing sponsors with actionable guidance to make confident, informed vendor choices.
-
Can Your Clinical Trial Design Handle Mid-Study Changes?
Mid-study changes are frequently inevitable, but it’s possible to reduce the downtime they create with strategic planning and technology. See how to plan for mid-study changes that mitigate downtime.
-
Finding The Optimal IRT/RTSM Design For Your Clinical Trial
Determine the best IRT/RTSM design for your trial through consideration of the user, data collection, and future-proofing.
-
Phase 4 Trials: A Critical Component Of Post-Marketing Insight
Uncover how Phase 4 trials play an essential role in gathering additional real-world data on the treatment’s performance over a longer period of time and in more diverse patient populations.
-
Kicking Off A Clinical Trial The Right Way - With Seamless Digital Consent
Read this blog to learn more about how eConsent can enhance participant engagement and retention when used both onsite and remotely.
-
Best Practices For Changing From One eClinical Vendor To Another
Switching solution providers mid-study isn't uncommon. But how can teams avoid schedule delays, interrupted operations, and errors? Learn best practices from this example by Signant Biotech.
-
Electronic Data Capture In Clinical Trials: What Needs To Improve?
Integrated technologies enhance clinical trial support, boosting the potential for quicker time-to-market. Key sponsors and CROs favoring operational efficiency prioritize "holistic study design," involving the integration of technologies (e.g., EDC, eCOA, and IRT) aligned with protocol, as opposed to constructing the study in individual tools.